Cargando…

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023

Detalles Bibliográficos
Autores principales:	McLean, Huong Q., Petrie, Joshua G., Hanson, Kayla E., Meece, Jennifer K., Rolfes, Melissa A., Sylvester, Gregg C., Neumann, Gabriele, Kawaoka, Yoshihiro, Belongia, Edward A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949852/ https://www.ncbi.nlm.nih.gov/pubmed/36821715 http://dx.doi.org/10.15585/mmwr.mm7208a1

Ejemplares similares

446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort
por: Sundaram, Maria, et al.
Publicado: (2023)

Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
por: Petrie, Joshua G., et al.
Publicado: (2023)

Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023
por: Kissling, Esther, et al.
Publicado: (2023)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
por: Chung, Jessie R., et al.
Publicado: (2022)

Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection — Tennessee and Wisconsin, April–September 2020
por: Rolfes, Melissa A., et al.
Publicado: (2021)

Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020
por: Grijalva, Carlos G., et al.
Publicado: (2020)

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents
por: Hanson, Kayla E., et al.
Publicado: (2019)

Estimate of COVID-19 Deaths, China, December 2022–February 2023
por: Du, Zhanwei, et al.
Publicado: (2023)

In the Limelight: February 2022
por: Nath, Karl A.
Publicado: (2022)

In the literature: February 2022
por: Gambardella, V., et al.
Publicado: (2022)

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022
por: Baker, Julia M., et al.
Publicado: (2022)

50-October 2022
Publicado: (2022)

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
por: Kim, Sara S., et al.
Publicado: (2022)

1356. Case Series of Children with Hepatitis and Adenovirus Infection, Alabama, October 2021—February 2022
por: Buchfellner, Markus A, et al.
Publicado: (2022)

Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022
por: Guthmann, Jean-Paul, et al.
Publicado: (2023)

Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents
por: Barnes, Kathrine L., et al.
Publicado: (2018)

Jahresrückblick 2022 – Jahresausblick 2023
por: Kerbl, Reinhold
Publicado: (2022)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

Student Medical Summit - Online 2022: Virtual. 5 February 2022
Publicado: (2022)

PRAC meeting highlights February 2022
Publicado: (2022)

Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023
por: Rao, Agam K., et al.
Publicado: (2023)

The “Reviewer of the Year” award 2022/2023
por: Kandziora, Frank, et al.
Publicado: (2023)

Contribution of community champions to accelerate the uptake of COVID-19 vaccination in Rukwa region, Tanzania, February - October 2022
por: Msunyaro, Erick, et al.
Publicado: (2023)

Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
por: Doyle, Joshua D., et al.
Publicado: (2019)

Standard Model Summary Plots February 2022
por: The ATLAS collaboration
Publicado: (2022)

Campbell title registrations to date—February 2022
Publicado: (2022)

Human vaccines & immunotherapeutics: news February 2022
Publicado: (2022)

1687. Unprecedented Outbreak of Invasive group A Streptococcus Infections in Children - Colorado, October 2022 to March 2023
por: Ho, Erin C, et al.
Publicado: (2023)

Predictors of COVID-19 Severity in Elderly Patients Infected by Omicron in China, 18 December 2022–5 February 2023
por: Xing, Yanqing, et al.
Publicado: (2023)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

Toroid cleaning at end of YETS 2022-2023
por: Goldfarb, Steven
Publicado: (2023)

Looking to 2023 and thanks to 2022 JADA contributors
por: Wright, J. Tim
Publicado: (2022)

2209. RSV-associated Hospitalizations in Adults Aged ≥18 Years and the Impact of the COVID-19 Pandemic in the United States, October 2018 – February 2022
por: Havers, Fiona P, et al.
Publicado: (2022)

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013
por: Jackson, Lisa, et al.
Publicado: (2013)

Human vaccines & immunotherapeutics: News October 2022
por: Ellis, Ronald, et al.
Publicado: (2022)

Acknowledgment to reviewers—November 2021 to October 2022
Publicado: (2023)

Abstracts from the CanVECTOR 2022 Annual Conference October 14th, 2022
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p1ro6j78u08s6elmd6f1uucr4p